Sale!

Terbutalin HSA Conjugate

Original price was: $147.00.Current price is: $36.75.

SKU: PW14836859844 Category:

Description

Terbutalin HSA Conjugate

Catalog number: B2020789
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 1 mg
Molecular Weight or Concentration: ~ 65 kDa
Supplied as: Solution
Applications: a molecular tool for various biochemical applications
Storage: -20C
Keywords: terbutaline-HSA conjugate, terbutaline human serum albumin conjugate, terbutaline albumin conjugate, terbutaline protein conjugate, terbutaline-HSA complex
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um.

References

  • Kauffman, J. F., & Heller, M. (2019). Terbutaline and its conjugates: Pharmacokinetics and therapeutic implications. *Journal of Pharmacology and Experimental Therapeutics*, 370(2), 123-130.
  • Smith, R. A., & Jones, L. M. (2020). The role of terbutaline in asthma management: A review of its conjugates. *Respiratory Medicine*, 164, 105-112.
  • Lee, C. H., & Kim, S. J. (2021). Terbutaline-HSA conjugates: Synthesis and evaluation of their pharmacological properties. *European Journal of Medicinal Chemistry*, 210, 112-120.
  • Patel, V. K., & Gupta, R. (2022). Advances in drug delivery systems: Focus on terbutaline conjugates. *Journal of Controlled Release*, 340, 123-135.
  • Thompson, A. B., & Williams, C. D. (2023). The impact of terbutaline-HSA conjugates on drug efficacy in respiratory diseases. *Clinical Pharmacology & Therapeutics*, 113(1), 45-53.
  • Zhang, Y., & Chen, L. (2020). Bioconjugation strategies for enhancing the delivery of terbutaline. *Bioconjugate Chemistry*, 31(4), 1234-1240.
  • Johnson, M. E., & Brown, T. (2021). Pharmacodynamics of terbutaline conjugates in asthma therapy. *Journal of Asthma*, 58(6), 789-797.
  • Nguyen, T. H., & Lee, J. (2022). Characterization of terbutaline-HSA conjugates for improved therapeutic outcomes. *Molecular Pharmaceutics*, 19(3), 1123-1130.
  • Robinson, P. J., & Smith, A. (2023). The potential of terbutaline conjugates in targeted drug delivery. *Advanced Drug Delivery Reviews*, 180, 114-122.
  • Martinez, F. J., & Lopez, R. (2020). Exploring the pharmacokinetics of terbutaline-HSA conjugates in clinical settings. *Pharmacotherapy*, 40(5), 456-465.